Amarin reported $111.83M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Adamas Pharmaceuticals ADMS:US 25.32M 3.88M
Aerie Pharmaceuticals AERI:US $ 21.41M 0.41M
Alnylam Pharmaceuticals ALNY:US $ 154.97M 35.33M
Amarin AMRN:US $ 111.83M 10.51M
AstraZeneca AZN:LN 6.04B 15M
Biocryst Pharmaceuticals BCRX:US $ 40.38M 9.24M
Epizyme EPZM:US $ 3.2M 7.32M
Esperion Therapeutics ESPR:US $ 8.85M 30.01M
GlaxoSmithKline GSK:LN 6.26B 682M
Halozyme Therapeutics HALO:US $ 97.24M 16.2M
Intercept Pharmaceuticals ICPT:US $ 92.17M 3.79M
IONIS PHARMACEUT IONS:US $ 130M 7.21M
JAZZ PHA JAZZ:US $ 692.89M 60.27M
Nektar Therapeutics NKTR:US $ 19.61M 1.05M
Neurocrine Biosciences NBIX:US $ 291.8M 6M
Novartis NOVN:VX 9.52B 21M
Teva Pharmaceutical Industries TEVA:US $ 1898M 25M